ENHYPEN add new dates to their 2024 to 2025 ‘Walk The Line’ world tour

K-pop boyband ENHYPEN have announced their ongoing 2024 to 2025 ‘Walk The Line’ world tour, currently featuring concerts in South Korea, Japan and Southeast Asia.

On September 2, ENHYPEN and their label Belift Lab announced the first batch of concerts for their ongoing 2024 to 2025 world tour, titled ‘Walk The Line’. The world tour will mark the third in the band’s career, with the previously, the 2023 to 2024 ‘Fate’ tour, having only concluded last month.

The seven-piece kicked off their 2024 to 2025 ‘Walk The Line’ world tour with two shows in October at the Goyang Stadium in South Korea. Thereafter, they will head to the Japanese cities of Saitama, Fukuoka and Osaka in November, December and January respectively for what the company has touted as their “biggest dome tour to date”.

On November 11, the girl group added two Southeast Asia dates to their ongoing 2024 to 2025 ‘Walk The Line’ world tour. It includes shows in the Philippines and Thailand, set to take place in March and June 2025.

Advertisement

Ticketing information for the newly added dates for ENHYPEN’s upcoming world tour have yet to be announced. Keep tabs on this page for the latest updates.

The dates for ENHYPEN’s 2024 to 2025 ‘Walk The Line’ world tour are:

OCTOBER 2024
05: Goyang, South Korea, Goyang Stadium (FINISHED)
06: Goyang, South Korea, Goyang Stadium (FINISHED)

NOVEMBER 2024
09: Saitama, Japan, Belluna Dome (FINISHED)
10: Saitama, Japan, Belluna Dome (FINISHED)

Recommended

DECEMBER 2024
28: Fukuoka, Japan, Mizuho PayPay Dome
29: Fukuoka, Japan, Mizuho PayPay Dome

JANUARY 2025
25: Osaka, Japan, Kyocera Dome
26: Osaka, Japan, Kyocera Dome

MARCH 2025
01: Bulacan, the Philippines, Philippine Sports Stadium

JUNE 2025
21: Bangkok, Thailand, Rajamangala National Stadium

Advertisement

In July 2024, ENHYPEN released their second studio album, ‘Romance: Untold’. In a glowing four-star reviewNME‘s Tanu I. Raj called the record “funky, sultry and incredibly addictive”.